NO832625L - Anellerte 4h-1,4-bensotiazoner, fremgangsmaate til deres fremstilling og ders anvendelse som legemiddel - Google Patents

Anellerte 4h-1,4-bensotiazoner, fremgangsmaate til deres fremstilling og ders anvendelse som legemiddel

Info

Publication number
NO832625L
NO832625L NO832625A NO832625A NO832625L NO 832625 L NO832625 L NO 832625L NO 832625 A NO832625 A NO 832625A NO 832625 A NO832625 A NO 832625A NO 832625 L NO832625 L NO 832625L
Authority
NO
Norway
Prior art keywords
general formula
compound
alkyl
alkoxy
optionally substituted
Prior art date
Application number
NO832625A
Other languages
English (en)
Norwegian (no)
Inventor
Ekkehardt Niemers
Rudi Gruetzmann
Mithat Mardin
Horst Meyer
Wolf-Dieter Busse
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO832625L publication Critical patent/NO832625L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO832625A 1982-08-04 1983-07-19 Anellerte 4h-1,4-bensotiazoner, fremgangsmaate til deres fremstilling og ders anvendelse som legemiddel NO832625L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823229122 DE3229122A1 (de) 1982-08-04 1982-08-04 Anellierte 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
NO832625L true NO832625L (no) 1984-02-06

Family

ID=6170117

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832625A NO832625L (no) 1982-08-04 1983-07-19 Anellerte 4h-1,4-bensotiazoner, fremgangsmaate til deres fremstilling og ders anvendelse som legemiddel

Country Status (16)

Country Link
US (1) US4636497A (cs)
EP (1) EP0101898A1 (cs)
JP (1) JPS5944370A (cs)
KR (1) KR840005725A (cs)
AU (1) AU1741483A (cs)
DE (1) DE3229122A1 (cs)
DK (1) DK354583A (cs)
ES (1) ES524713A0 (cs)
FI (1) FI832784A7 (cs)
GR (1) GR79355B (cs)
HU (1) HU189314B (cs)
IL (1) IL69388A0 (cs)
NO (1) NO832625L (cs)
PH (1) PH18784A (cs)
PT (1) PT77097B (cs)
ZA (1) ZA835673B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138481B1 (en) * 1983-10-05 1991-06-26 Merck Frosst Canada Inc. Leukotriene biosynthesis inhibitors
EP0149297B1 (en) * 1983-12-27 1987-11-25 Merck Frosst Canada Inc. Process for preparing 3h-phenothlazin-3-ones
EP0155623A3 (en) * 1984-03-19 1985-12-27 Merck & Co. Inc. Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition
US4500708A (en) * 1984-04-23 1985-02-19 G. D. Serle & Co. Benzothiazine derivatives
DE3426564A1 (de) * 1984-07-19 1986-01-30 Bayer Ag, 5090 Leverkusen Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind
DE3540702A1 (de) * 1985-11-16 1987-05-21 Bayer Ag 1h-pyrido-(2,3-b) (1,4)-thiazine
DE3545097A1 (de) * 1985-12-19 1987-07-02 Bayer Ag 1-h-pyrido-(3,2-b)(1,4)-thiazine
US4921838A (en) * 1987-06-16 1990-05-01 Trustees Of Boston University Angiogenic and blood perfusion inducing properties of amphiphilic compounds
US5981294A (en) * 1995-11-29 1999-11-09 Metrika, Inc. Device for blood separation in a diagnostic device
US5994349A (en) * 1997-10-27 1999-11-30 Howard University 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives
RU2167156C1 (ru) * 2000-02-11 2001-05-20 Государственный научный центр РФ "НИОПИК" Способ получения 2-трифторметилфенотиазина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1088055B (de) * 1958-05-16 1960-09-01 Chem Fab Promonta Ges Mit Besc Verfahren zur Herstellung von Hexahydrophenthiazin-9-dioxyden
DE1151802B (de) * 1960-04-28 1963-07-25 Chem Fab Promonta Ges Mit Besc Verfahren zur Herstellung von cycloalkylierten 2,3-Dihydro-1,4-benzthiazinen
US3422101A (en) * 1967-05-05 1969-01-14 Mcneilab Inc Tetrahydrothienobenzothiazines
US4512990A (en) * 1982-02-18 1985-04-23 Syntex (U.S.A.), Inc. Benzthiazine analogs as antiinflammatory agents

Also Published As

Publication number Publication date
HU189314B (en) 1986-06-30
FI832784L (fi) 1984-02-05
ZA835673B (en) 1984-04-25
GR79355B (cs) 1984-10-22
FI832784A7 (fi) 1984-02-05
IL69388A0 (en) 1983-11-30
PT77097A (en) 1983-08-01
ES8404607A1 (es) 1984-05-01
EP0101898A1 (de) 1984-03-07
JPS5944370A (ja) 1984-03-12
KR840005725A (ko) 1984-11-16
DK354583A (da) 1984-02-05
AU1741483A (en) 1984-02-09
FI832784A0 (fi) 1983-08-02
DK354583D0 (da) 1983-08-03
ES524713A0 (es) 1984-05-01
DE3229122A1 (de) 1984-02-09
PT77097B (en) 1986-03-12
PH18784A (en) 1985-09-25
US4636497A (en) 1987-01-13

Similar Documents

Publication Publication Date Title
US4552874A (en) Pyrazolooxazines, pyrazolothiazines, and pryazoloquinolines and their use as medicaments
US5594015A (en) Thiazolidine derivatives for the treatment of psoriasis
DE69828276T2 (de) Neue cyclische Diaminverbindungen und Heilmittel das diese enthält
US5002941A (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
EP0022317B1 (en) 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives
US5104889A (en) Thiazole derivatives
CS399991A3 (en) Amide derivatives
NO832625L (no) Anellerte 4h-1,4-bensotiazoner, fremgangsmaate til deres fremstilling og ders anvendelse som legemiddel
US6969711B2 (en) Cyclic diamine compounds and medicine containing the same
US6204278B1 (en) Anilide compounds, including use thereof in ACAT inhibitition
KR102321814B1 (ko) (＋)-5-(3,4-디플루오로페닐)-5-[(3-메틸-2-옥소피리딘-1(2h)-일)메틸]이미다졸리딘-2,4-디온 및 그것을 함유하는 의약
US5145858A (en) Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
EP0319170B1 (en) Acyl derivatives of hydroxy pyrimidines
DE69830600T2 (de) Anilidverbindungen und medikamente, die diese enthalten
EP0229496B1 (en) Inhibition of the 5-lipoxygenase pathway
NO832664L (no) 4h-1,4-benzothiazin, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel
EP0055917B1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof
CZ282165B6 (cs) Cyklické deriváty aminofenyloctové kyseliny, způsob jejich výroby a léčiva na jejich bázi
JPS6216469A (ja) ２−置換シクロヘプトイミダゾ−ル誘導体、抗潰瘍剤及びその製造方法
US6849647B1 (en) Amide compounds and medications containing the same technical field
JPH03135957A (ja) 置換（キノリン‐２‐イル‐メトキシ）フェニル‐チオ尿素類
NO834401L (no) Pyrazolo(4.3-b)(1.4)oxasiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
JPH0931062A (ja) ベンズイミダゾール化合物
JPH0940669A (ja) ベンズイミダゾール化合物